23 results
8-K
EX-10.1
CRVO
CervoMed Inc
16 Dec 22
Diffusion Pharmaceuticals Announces Agreement with LifeSci Special Opportunities
5:10pm
consideration, the receipt and sufficiency of which is hereby acknowledged, the parties agree as follows:
Withdrawal of LifeSci Proxy Contest
DEFA14A
EX-99.1
CRVO
CervoMed Inc
5 Dec 22
Additional proxy soliciting materials
9:59pm
unsolicited offer, but LifeSci instead chose to launch a proxy contest against our highly qualified board
LifeSci’s track record demonstrates … on November 17, 2022, the commencement of a proxy contest on its own behalf, nominating a slate of directors for election at our upcoming annual
8-K
EX-99.1
CRVO
CervoMed Inc
5 Dec 22
Diffusion has a highly engaged and independent board that possesses the right skills and experience to execute the strategic review process
9:58pm
unsolicited offer, but LifeSci instead chose to launch a proxy contest against our highly qualified board
LifeSci’s track record demonstrates … on November 17, 2022, the commencement of a proxy contest on its own behalf, nominating a slate of directors for election at our upcoming annual
DEFC14A
tjgrl 7kdqu9
5 Dec 22
Proxy in contested solicitation
5:12pm
DEFA14A
8s4lue8hdou sfaogoh
1 Dec 22
Additional proxy soliciting materials
4:34pm
8-K
zzofdr9gr4nncku qvk
1 Dec 22
Other Events
4:34pm
PRER14A
qydhs84q rm2ah8
28 Nov 22
Preliminary revised proxy
5:17pm
PREC14A
5yr09y7vdt0qa9jj
18 Nov 22
Preliminary proxy with contested solicitation
5:08pm
8-K
EX-99.1
vu8iuv7lh auit9k6yz1
18 Nov 22
Diffusion Pharmaceuticals Sees Significant Progress in its Strategic Review Process
4:40pm
DEFA14A
EX-99.1
0gzgkdc8y9t1ib w4j
14 Nov 22
Additional proxy soliciting materials
7:41am
8-K
EX-99.1
ec6qrfq5o0bhtwao7
14 Nov 22
Diffusion Pharmaceuticals Sees Significant Progress in its Strategic Review Process
7:40am